The Supreme Court of Korea has sided with SK in an ongoing patent feud with Pfizer, ruling that the Korean company did not violate a composition patent on Pfizer’s pneumococcal shot Prevnar 13 by shipping components and finished research doses
read moreFDA Commissioner Marty Makary, M.D., and CBER head Vinay Prasad, M.D., detailed their new approach to COVID vaccines in a Tuesday update. The agency leaders say they’re pursuing an “evidence-based approach to COVID-19 vaccination.” More: FDA lays out stricter COVID
read moreRoche looks unlikely to be able to move its DLBCL drug Columvi earlier in the treatment sequence after experts on an FDA advisory committee joined the agency in questioning the regional imbalance of clinical trial data. What’s more, both FDA
read more
Brekiya is now the first DHE auto-injector to be approved by the regulator More: FDA approves Amneal’s self-administered migraine drug Brekiya Source: News
read moreDrugmakers looking to broaden their appeal among healthcare professionals can forgo flashy gimmicks and lavish freebies—what doctors really want, according to a new report, is access to practical, helpful information. More: Doctors want more educational, financial info from pharmas: report
read moreSK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In a new nationwide direct-to-consumer ad, the Xcopri manufacturer asks partial-onset seizure patients to consider switching to a new treatment. More:
read more© 1994 - 2026 B.M. Pharmaceuticals